This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glyconex, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Ying-Jin Chen in Glycosphingolipid Research
Introduction
Ying-Jin Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of glycosphingolipid research. His work focuses on human antibodies and their specific binding to extended Type I chain glycosphingolipids.
Latest Patents
Ying-Jin Chen holds a patent for an "Anti-extended type I glycosphingolipid antibody, derivatives thereof and use." This patent includes human antibodies and antigen-binding portions that specifically target extended Type I chain glycosphingolipids. He has 1 patent to his name.
Career Highlights
Ying-Jin Chen is currently associated with Glyconex, Inc., where he continues to advance research in his field. His innovative work has the potential to impact various applications in medicine and biotechnology.
Collaborations
He has collaborated with notable colleagues, including Tong-Hsuan Chang and Jerry Ting, to further enhance the research and development of glycosphingolipid-related technologies.
Conclusion
Ying-Jin Chen's contributions to glycosphingolipid research exemplify the importance of innovation in the field of biotechnology. His work continues to pave the way for future advancements in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile